Gomes LEM, Silva FAR da, Pascoal LB, Ricci RL, Nogueira G, Camargo MG, et al. Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics [Internet]. 2019 Oct. 9 [cited 2024 Jul. 4];74:e1517. Available from: https://periodicos.usp.br/clinics/article/view/163040